Clinical Trials Logo

Neurologic Manifestations clinical trials

View clinical trials related to Neurologic Manifestations.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03913130 Terminated - Eye Diseases Clinical Trials

Extension Study to Study PQ-110-001 (NCT03140969)

INSIGHT
Start date: May 13, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Subjects completing participation in study PQ-110-001 (EudraCT 2017-000813-22 / NCT03140969) will be given the opportunity to enroll into the extension study for continued dosing if available data support current and/or future benefits for the subject. Study PQ-110-002 will provide long-term safety, tolerability, pharmacokinetic (PK), and efficacy data of QR-110.

NCT ID: NCT03879655 Terminated - Clinical trials for Niemann-Pick Disease, Type C

Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1

Start date: December 2, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

This is a multicenter, multinational, open-label study of VTS-270 to evaluate the long-term safety and tolerability of VTS-270 (2-hydroxypropyl-β-cyclodextrin) in participants transitioning from Study VTS301 (Parts A/B [NCT02534844] and Part C [NCT04958642]) with neurologic manifestations of Niemann-Pick Type C1 (NPC1) disease.

NCT ID: NCT03768401 Terminated - Physical Disability Clinical Trials

Accessible Mobile Health and Wellness

CHAMPs
Start date: August 1, 2018
Phase: N/A
Study type: Interventional

Can community outreach education help develop self-sustaining wellness and exercise programs, and will associated wellness clinics help persons with a neurological physical disability achieve better well-being?

NCT ID: NCT03558750 Terminated - Clinical trials for Refractory Diffuse Large B-Cell Lymphoma

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Start date: June 14, 2018
Phase: Phase 1
Study type: Interventional

This phase I/II trial studies the side effects and best dose of lenalidomide when given in combination with rituximab and nivolumab and how well they work in treating participants with non-germinal center type diffuse large B cell lymphoma or primary central nervous system lymphoma that has come back or isn't responding to treatment. Monoclonal antibodies, such as rituximab and nivolumab, may interfere with ability of cancer cells to grow and spread. Drugs used in chemotherapy, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving rituximab, lenalidomide, and nivolumab may work better in treating participants with diffuse large B cell lymphoma.

NCT ID: NCT03270189 Terminated - Clinical trials for Nervous System Diseases

Effect of the Visual Information Change in Functional Dystonia

PRISMADYS
Start date: September 18, 2017
Phase: N/A
Study type: Interventional

Cervical dystonia occurring only during the writing task is a rare form for which there is no established treatment. Many authors agree that alteration of sensory integration is associated with dystonia. Similar disturbances in the integration of oculomotor information could have a role in cervical dystonia forms involving visuo-cervico-manual coordination such as handwriting. We hypothesize that orthoptic treatment by wearing prisms when writing (i) will reduce the abnormal posture of the head occurring whilst writing and remove the associated nuchal pain; (ii) the correction after a period of systematic wearing of the prisms during handwriting tasks will have a sustainable effect allowing to keep a normal head position after the suppression of the prisms.

NCT ID: NCT01461005 Terminated - Spondylolisthesis Clinical Trials

A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS)

DSS
Start date: September 2011
Phase: N/A
Study type: Interventional

The purpose of the Post-Market Surveillance study is to evaluate safety.

NCT ID: NCT00137527 Terminated - Clinical trials for Neurological Manifestations

Brain Oxygenation Monitoring in Patients Undergoing Coronary Artery Bypass Surgery

Start date: February 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether intraoperative brain oxygenation monitoring in cardiac surgery patients is effective in reducing postoperative neurologic and neurocognitive dysfunction.

NCT ID: NCT00123539 Terminated - Clinical trials for Cardiovascular Diseases

Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery

Start date: June 2001
Phase: N/A
Study type: Interventional

The purpose of this study is to test whether perioperative estrogen replacement in postmenopausal women reduces the risk for neurologic injury after coronary artery bypass graft (CABG) surgery.

NCT ID: NCT00006321 Terminated - Lung Diseases Clinical Trials

Neurocognitive Function in Snoring Children

Start date: September 1999
Phase: N/A
Study type: Observational

To assess associations between behavioral/neuropsychological measures and various measures of sleep disordered breathing (SDB) and to determine the prevalence of SDB in children with Attention Deficit Hyperactivity Disorder (ADHD).